At a glance
- Originator Eli Lilly and Company
- Class Antivirals; Nitriles; Small molecules; Thiadiazoles
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
Most Recent Events
- 20 Oct 1994 No-Development-Reported for Influenza virus infections in USA (Unknown route)